The Brady Laboratory is dedicated to advancing the understanding of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), a rapidly growing health concern and the most common chronic liver disease worldwide. Through cutting-edge research, the team is working to uncover the mechanisms that drive disease progression and to develop new strategies for prevention and treatment. Your support helps fuel these breakthroughs—accelerating discoveries, training the next generation of scientists, and bringing hope to patients and families affected by liver disease.

Contact Internal Medicine Development